+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes



IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes



Journal of Clinical Investigation 130: 3625-3639



Type 1 IFNs (IFN-I) generally protect mammalian hosts from virus infections, but in some cases, IFN-I is pathogenic. Because IFN-I is protective, it is commonly used to treat virus infections for which no specific approved drug or vaccine is available. The Middle East respiratory syndrome-coronavirus (MERS-CoV) is such an infection, yet little is known about the role of IFN-I in this setting. Here, we show that IFN-I signaling is protective during MERS-CoV infection. Blocking IFN-I signaling resulted in delayed virus clearance, enhanced neutrophil infiltration, and impaired MERS-CoV-specific T cell responses. Notably, IFN-I administration within 1 day after infection (before virus titers peak) protected mice from lethal infection, despite a decrease in IFN-stimulated gene (ISG) and inflammatory cytokine gene expression. In contrast, delayed IFN-β treatment failed to effectively inhibit virus replication, increased infiltration and activation of monocytes, macrophages, and neutrophils in the lungs, and enhanced proinflammatory cytokine expression, resulting in fatal pneumonia in an otherwise sublethal infection. Together, these results suggest that the relative timing of the IFN-I response and maximal virus replication is key in determining outcomes, at least in infected mice. By extension, IFN-αβ or combination therapy may need to be used cautiously to treat viral infections in clinical settings.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 069192775

Download citation: RISBibTeXText

PMID: 31355779


Related references

Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. Bmc Infectious Diseases 16: 174, 2016

Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model. Virus Research 228: 7, 2017

Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clinical Microbiology and Infection 22(10): 880-886, 2016

An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. Journal of Infectious Diseases 209(2): 236-242, 2014

The timing of the immune response in relation to virus growth determines the outcome of the LCM infection. Acta Pathologica et Microbiologica Scandinavica. Section C Immunology 87c(1): 47-54, 1979

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection. Journal of Infectious Diseases 213(10): 1557-1561, 2016

The timing of the immune response in relation to virus growth determines the outcome of the lymphocytic chorio meningitis infection. Acta Pathologica et Microbiologica Scandinavica Section C Immunology 87(1): 47-54, 1979

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. Mmwr. Morbidity and Mortality Weekly Report 63(19): 431-436, 2014

A poxvirus-based vaccine reduces virus excretion after MERS coronavirus infection in dromedary camels. International Journal of Infectious Diseases 45: 421-422, 2016

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development. Journal of Immunology Research 2019: 6491738, 2019

The critical care response to a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: an observational study. Annals of Intensive Care 6(1): 101, 2016

Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro Surveillance 19(18):, 2014

Cell cycle perturbations induced by infection with the coronavirus infectious bronchitis virus and their effect on virus replication. Journal of Virology 80(8): 4147-4156, 2006

Coronavirus infection in mink (Mustela vison). Serological evidence of infection with a coronavirus related to transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Veterinary Microbiology 31(1): 1-10, 1992

Human immunodeficiency virus infection of monoblastoid cells: cellular differentiation determines the pattern of virus replication. Journal of Virology 62(10): 3558-3564, 1988